Results 191 to 200 of about 122,153 (397)

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

open access: yesBritish Journal of Pharmacology, EarlyView.
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli   +7 more
wiley   +1 more source

Pharmacokinetics of Cannabinoids

open access: yesPain Research and Management, 2005
Delta‐9‐tetrahydrocannabinol (Δ‐9‐THC) is the main psychoactive ingredient of cannabis (marijuana). The present review focuses on the pharmacokinetics of THC, but also includes known information for cannabinol and cannabidiol, as well as the synthetic marketed cannabinoids, dronabinol (synthetic THC) and nabilone.
openaire   +3 more sources

Sex‐specific impact of repeated adolescent vapour exposure to JWH‐018 on dopamine response, behaviour and pharmacokinetics across adolescence and adulthood

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Alarming trends show that vaping e‐cigarettes containing synthetic cannabinoid receptor agonists, such as JWH‐018, is increasing among youth. However, the effects of these trends are unclear in both sexes. We therefore characterized the neuropharmacological effects of adolescent JWH‐018 inhalation in male and female rats.
Nicholas Pintori   +7 more
wiley   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus   +5 more
wiley   +1 more source

Synthetic cannabinoids

open access: yesNorthern Clinics of Istanbul, 2014
Use of cannabinoids is increasing at an alarming rate. Their easy availability, cheapness, perceptive legality and difficulty in detecting its presence with standard urine toxicologic tests, and similar factors probably contribute to the increased use, and popularity of synthetic cannabinoids. Although laws, and regulations concerning auditing of these
openaire   +2 more sources

Cannabinoids in disguise: Δ9-Tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles

open access: green, 2013
Jenny L. Wiley   +5 more
openalex   +1 more source

Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.

open access: yesJournal of the American Medical Association (JAMA), 2015
P. Whiting   +14 more
semanticscholar   +1 more source

CBD Hemp Pharming in Illinois: Working to Legitimize an Enduringly Illicit Crop

open access: yesCulture, Agriculture, Food and Environment, EarlyView.
ABSTRACT Based on interviews and participant observation activities conducted in 2024, this article investigates the perspectives and experiences of Illinois farmers cultivating CBD (cannabidiol) hemp. The 2018 U.S. Farm Bill legalized hemp, defined as cannabis containing < 0.3% delta‐9 tetrahydrocannabinol (THC), the intoxicating compound found in ...
Megan A. Styles, Courtney R. Roberts
wiley   +1 more source

Fluorescence of cannabinoids

open access: yesJournal of Pharmacy and Pharmacology, 1975
DIONYSSIOUASTER.A, MIRAS, CJ
openaire   +3 more sources

Home - About - Disclaimer - Privacy